{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:27:36Z","timestamp":1790731656476,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00592-019-01374-x","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T05:50:11Z","timestamp":1560405011000},"page":"1199-1207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients"],"prefix":"10.1007","volume":"56","author":[{"given":"Asieh","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Mohajeri-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Samadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadis","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Qorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Bellissimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"issue":"3","key":"1374_CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/dc16-1787","volume":"40","author":"F Bril","year":"2017","unstructured":"Bril F, Cusi K (2017) Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action. Diabetes Care 40(3):419\u2013430","journal-title":"Diabetes Care"},{"issue":"1","key":"1374_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11739-015-1346-x","volume":"11","author":"L Miele","year":"2016","unstructured":"Miele L, Gasbarrini G, Giorgio V, Gasbarrini A, Grieco A (2016) Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome. Intern Emerg Med 11(1):3\u201310","journal-title":"Intern Emerg Med"},{"issue":"2","key":"1374_CR3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","volume":"41","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Byrne CD, Bonora E, Targher G (2018) Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care 41(2):372\u2013382","journal-title":"Diabetes Care"},{"issue":"5","key":"1374_CR4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","volume":"31","author":"S Ballestri","year":"2016","unstructured":"Ballestri S, Zona S, Targher G et al (2016) Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol 31(5):936\u2013944","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"1374_CR5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","volume":"43","author":"G Musso","year":"2011","unstructured":"Musso G, Gambino R, Cassader M, Pagano G (2011) Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43(8):617\u2013649","journal-title":"Ann Med"},{"issue":"1","key":"1374_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jhep.2017.09.020","volume":"68","author":"M-W Yeung","year":"2018","unstructured":"Yeung M-W, Wong GL-H, Choi KC et al (2018) Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes. J Hepatol 68(1):147\u2013156","journal-title":"J Hepatol"},{"issue":"12","key":"1374_CR7","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/ajg.2013.349","volume":"108","author":"Y Chang","year":"2013","unstructured":"Chang Y, Jung H-S, Yun KE, Cho J, Cho YK, Ryu S (2013) Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am J Gastroenterol 108(12):1861","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1374_CR8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","volume":"41","author":"E Han","year":"2017","unstructured":"Han E, Lee Y-h (2017) Non-alcoholic fatty liver disease: the emerging burden in cardiometabolic and renal diseases. Diabetes Metab J 41(6):430\u2013437","journal-title":"Diabetes Metab J"},{"issue":"6","key":"1374_CR9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","volume":"118","author":"V Ratziu","year":"2000","unstructured":"Ratziu V, Giral P, Charlotte F et al (2000) Liver fibrosis in overweight patients. Gastroenterology 118(6):1117\u20131123","journal-title":"Gastroenterology"},{"issue":"9","key":"1374_CR10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/liv.13397","volume":"37","author":"S Petta","year":"2017","unstructured":"Petta S, Eslam M, Valenti L et al (2017) Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: an age-dependent risk profiling study. Liver Int 37(9):1389\u20131396","journal-title":"Liver Int"},{"issue":"1","key":"1374_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jgh.12432","volume":"29","author":"\u00c1 Mena","year":"2014","unstructured":"Mena \u00c1, Pedreira JD, Castro \u00c1, L\u00f3pez S, V\u00e1zquez P, Poveda E (2014) Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers. J Gastroenterol Hepatol 29(1):173\u2013178","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1374_CR12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/2050640617751252","volume":"6","author":"S Cai","year":"2018","unstructured":"Cai S, Ou Z, Liu D et al (2018) Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome. United Eur Gastroenterol J 6(4):558\u2013566","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"1374_CR13","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","volume":"125","author":"JM Hui","year":"2003","unstructured":"Hui JM, Sud A, Farrell GC et al (2003) Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 125(6):1695\u20131704","journal-title":"Gastroenterology"},{"issue":"37","key":"1374_CR14","doi-asserted-by":"crossref","first-page":"e12356","DOI":"10.1097\/MD.0000000000012356","volume":"97","author":"H Zhao","year":"2018","unstructured":"Zhao H, Song X, Li Z, Wang X (2018) Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitus. Medicine 97(37):e12356","journal-title":"Medicine"},{"issue":"5","key":"1374_CR15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/qjmed\/hcr233","volume":"105","author":"R Williamson","year":"2011","unstructured":"Williamson R, Price J, Hayes P et al (2011) Prevalence and markers of advanced liver disease in type 2 diabetes. QJM Int J Med 105(5):425\u2013432","journal-title":"QJM Int J Med"},{"issue":"1","key":"1374_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11901-012-0160-4","volume":"12","author":"JP Domanski","year":"2013","unstructured":"Domanski JP, Harrison SA (2013) The AST to ALT ratio: a pattern worth considering. Curr Hepat Rep 12(1):47\u201352","journal-title":"Curr Hepat Rep"},{"issue":"6","key":"1374_CR17","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","volume":"37","author":"P Mofrad","year":"2003","unstructured":"Mofrad P, Contos MJ, Haque M et al (2003) Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37(6):1286\u20131292","journal-title":"Hepatology"},{"issue":"3","key":"1374_CR18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM et al (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123(3):745\u2013750","journal-title":"Gastroenterology"},{"issue":"17","key":"1374_CR19","doi-asserted-by":"crossref","first-page":"e0462","DOI":"10.1097\/MD.0000000000010462","volume":"97","author":"R Mohr","year":"2018","unstructured":"Mohr R, Boesecke C, Dold L et al (2018) Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis. Medicine 97(17):e0462","journal-title":"Medicine"},{"issue":"5","key":"1374_CR20","first-page":"426","volume":"13","author":"F Azizi","year":"2010","unstructured":"Azizi F, Hadaegh F, Khalili D et al (2010) Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med 13(5):426","journal-title":"Arch Iran Med"},{"issue":"1","key":"1374_CR21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jhep.2004.09.022","volume":"42","author":"A Muzzi","year":"2005","unstructured":"Muzzi A, Leandro G, Rubbia-Brandt L et al (2005) Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 42(1):41\u201346","journal-title":"J Hepatol"},{"issue":"5","key":"1374_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4254\/wjh.v3.i5.99","volume":"3","author":"T Kawaguchi","year":"2011","unstructured":"Kawaguchi T, Taniguchi E, Itou M, Sakata M, Sumie S, Sata M (2011) Insulin resistance and chronic liver disease. World J Hepatol 3(5):99","journal-title":"World J Hepatol"},{"issue":"4","key":"1374_CR23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","volume":"34","author":"V Paradis","year":"2001","unstructured":"Paradis V, Perlemuter G, Bonvoust F et al (2001) High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34(4):738\u2013744","journal-title":"Hepatology"},{"issue":"3","key":"1374_CR24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","volume":"8","author":"E Leighton","year":"2017","unstructured":"Leighton E, Sainsbury CA, Jones GC (2017) A practical review of C-peptide testing in diabetes. Diabetes Ther 8(3):475\u2013487","journal-title":"Diabetes Ther"},{"issue":"32","key":"1374_CR25","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3748\/wjg.v24.i32.3663","volume":"24","author":"A Atsawarungruangkit","year":"2018","unstructured":"Atsawarungruangkit A, Chenbhanich J, Dickstein G (2018) C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. World J Gastroenterol 24(32):3663","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1374_CR26","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1210\/en.2012-2167","volume":"154","author":"FT van Genderen","year":"2013","unstructured":"van Genderen FT, Gorus FK, Pipeleers DG, van Schravendijk CF (2013) Sensitive and specific time-resolved fluorescence immunoassay of rat C-peptide for measuring hormone secretory and storage capacity of \u03b2-cells in vivo and in vitro. Endocrinology 154(5):1934\u20131939","journal-title":"Endocrinology"},{"issue":"1","key":"1374_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-13-7","volume":"13","author":"S-Y Chai","year":"2014","unstructured":"Chai S-Y, Pan X-Y, Song K-X et al (2014) Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone. Lipids Health Dis 13(1):7","journal-title":"Lipids Health Dis"},{"key":"1374_CR28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/dc15-1876","volume":"39","author":"R Lomonaco","year":"2016","unstructured":"Lomonaco R, Bril F, Portillo-Sanchez P et al (2016) Metabolic impact of nonalcoholic steatohepatitis in obese patients with type 2 diabetes. Diabetes Care 39:632\u2013638","journal-title":"Diabetes Care"},{"issue":"1","key":"1374_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","volume":"135","author":"A Kotronen","year":"2008","unstructured":"Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-J\u00e4rvinen H (2008) Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135(1):122\u2013130","journal-title":"Gastroenterology"},{"issue":"6","key":"1374_CR30","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/hep.26988","volume":"59","author":"F Bril","year":"2014","unstructured":"Bril F, Lomonaco R, Orsak B et al (2014) Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis. Hepatology 59(6):2178\u20132187","journal-title":"Hepatology"},{"issue":"6","key":"1374_CR31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.51.6.870","volume":"51","author":"AV Greco","year":"2002","unstructured":"Greco AV, Mingrone G, Mari A, Capristo E, Manco M, Gasbarrini G (2002) Mechanisms of hyperinsulinaemia in Child\u2019s disease grade B liver cirrhosis investigated in free living conditions. Gut 51(6):870\u2013875","journal-title":"Gut"},{"issue":"8","key":"1374_CR32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jdiacomp.2018.05.008","volume":"32","author":"PJ Patel","year":"2018","unstructured":"Patel PJ, Hossain F, Horsfall LU et al (2018) Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. J Diabetes Complicat 32(8):799\u2013804","journal-title":"J Diabetes Complicat"},{"issue":"5","key":"1374_CR33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2337\/diabetes.49.5.749","volume":"49","author":"L Ryysy","year":"2000","unstructured":"Ryysy L, H\u00e4kkinen A-M, Goto T et al (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49(5):749\u2013758","journal-title":"Diabetes"},{"issue":"4","key":"1374_CR34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00592-018-1266-0","volume":"56","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Lugari S, Ballestri S, Nascimbeni F, Baldelli E, Maurantonio M (2019) A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? Acta Diabetol 56(4):385\u2013396","journal-title":"Acta Diabetol"},{"key":"1374_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-019-01303-y","author":"N Spreghini","year":"2019","unstructured":"Spreghini N, Cianfarani S, Spreghini MR et al (2019) Oral glucose effectiveness and metabolic risk in obese children and adolescents. Acta Diabetol. \nhttps:\/\/doi.org\/10.1007\/s00592-019-01303-y","journal-title":"Acta Diabetol"},{"key":"1374_CR36","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/gut.2007.142919","volume":"57","author":"M Manco","year":"2008","unstructured":"Manco M, Bedogni G, Marcellini M et al (2008) Waist circumference correlates with liver fibrosis in children with non alcoholic steatohepatitis. Gut 57:1283\u20131287","journal-title":"Gut"},{"issue":"1","key":"1374_CR37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1741-7015-7-21","volume":"7","author":"V Nobili","year":"2009","unstructured":"Nobili V, Alisi A, Vania A, Tiribelli C, Pietrobattista A, Bedogni G (2009) The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med 7(1):21","journal-title":"BMC Med"},{"issue":"2","key":"1374_CR38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","volume":"48","author":"D van der Poorten","year":"2008","unstructured":"van der Poorten D, Milner KL, Hui J et al (2008) Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48(2):449\u2013457","journal-title":"Hepatology"},{"issue":"1","key":"1374_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/1319-3767.91738","volume":"18","author":"NM El-Koofy","year":"2012","unstructured":"El-Koofy NM, Anwar GM, El-Raziky MS et al (2012) The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight\/obese children. Saudi J Gastroenterol 18(1):44","journal-title":"Saudi J Gastroenterol"},{"issue":"1","key":"1374_CR40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","volume":"67","author":"PN Newsome","year":"2018","unstructured":"Newsome PN, Cramb R, Davison SM et al (2018) Guidelines on the management of abnormal liver blood tests. Gut 67(1):6\u201319","journal-title":"Gut"},{"issue":"10","key":"1374_CR41","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.2337\/dc07-0106","volume":"30","author":"NH Cho","year":"2007","unstructured":"Cho NH, Jang HC, Choi SH et al (2007) Abnormal liver function test predicts type 2 diabetes: a community-based prospective study. Diabetes Care 30(10):2566\u20132568","journal-title":"Diabetes Care"},{"issue":"12","key":"1374_CR42","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.2337\/diacare.28.12.2913","volume":"28","author":"SG Wannamethee","year":"2005","unstructured":"Wannamethee SG, Shaper AG, Lennon L, Whincup PH (2005) Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28(12):2913\u20132918","journal-title":"Diabetes Care"},{"issue":"3","key":"1374_CR43","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","volume":"95","author":"AL Williams","year":"1988","unstructured":"Williams AL, Hoofnagle JH (1988) Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis relationship to cirrhosis. Gastroenterology 95(3):734\u2013739","journal-title":"Gastroenterology"},{"issue":"4","key":"1374_CR44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1440-1746.2000.02172.x","volume":"15","author":"GJH Park","year":"2000","unstructured":"Park GJH, Lin BP, Ngu MC, Jones DB, Katelaris PH (2000) Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol 15(4):386\u2013390","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"1374_CR45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jvh.12279","volume":"21","author":"E Teshale","year":"2014","unstructured":"Teshale E, Lu M, Rupp L et al (2014) APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CH e CS). J Viral Hepatitis 21(12):917\u2013920","journal-title":"J Viral Hepatitis"},{"issue":"2","key":"1374_CR46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archinte.163.2.218","volume":"163","author":"E Giannini","year":"2003","unstructured":"Giannini E, Risso D, Botta F et al (2003) Validity and clinical utility of the aspartate aminotransferase\u2013alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 163(2):218\u2013224","journal-title":"Arch Intern Med"},{"issue":"4","key":"1374_CR47","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.22109","volume":"47","author":"WR Kim","year":"2008","unstructured":"Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47(4):1363\u20131370","journal-title":"Hepatology"},{"issue":"6","key":"1374_CR48","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ajg.2013.5","volume":"108","author":"S Singh","year":"2013","unstructured":"Singh S, Singh PP, Singh AG, Murad MH, Sanchez W (2013) Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis. Am J Gastroenterol 108(6):881","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1374_CR49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00592-017-1024-8","volume":"54","author":"L Li","year":"2017","unstructured":"Li L, You W, Ren W (2017) The ZJU index is a powerful index for identifying NAFLD in the general Chinese population. Acta Diabetol 54(10):905\u2013911","journal-title":"Acta Diabetol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01374-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T23:40:21Z","timestamp":1591918821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01374-x","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"28 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were in accordance with the ethical standards of the institutional research committee (Ethics Committee of the National Institute for Medical Research Development and National Nutrition and Food Technology Research Institute) and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}